The Barcelona-Asymptomatic Intracranial Atherosclerosis (AsIA) study: Subclinical cervico-cerebral stenosis and middle cerebral artery pulsatility index as predictors of long-term incident cognitive impairment.


Journal

Atherosclerosis
ISSN: 1879-1484
Titre abrégé: Atherosclerosis
Pays: Ireland
ID NLM: 0242543

Informations de publication

Date de publication:
11 2020
Historique:
received: 07 06 2020
revised: 19 07 2020
accepted: 28 08 2020
pubmed: 15 9 2020
medline: 24 6 2021
entrez: 14 9 2020
Statut: ppublish

Résumé

We aimed to study subclinical non-invasive vascular markers as predictors of incident long-term cognitive impairment in a longitudinal population-based study. The Barcelona-Asymptomatic Intracranial Atherosclerosis (AsIA) study is a population-based study that included a random sample of 933 Caucasian subjects (mean age 66 years, 64% male) with a moderate-high vascular risk and without history of stroke or dementia. Subclinical carotid and intracranial stenosis was assessed at baseline visit by cervical and transcranial color-coded duplex (TCCD) and confirmed by magnetic resonance angiography. Cervico-cerebral stenosis (CCS) was defined as the presence of extra and/or intracranial stenosis >50%. Baseline middle cerebral artery pulsatility index (MCA-PI) was measured bilaterally by TCCD, and mean PI of both sides was considered for analyses. Subjects were followed-up to determine incident long-term cognitive impairment (mild cognitive impairment or dementia). After a median of 7.16 [6.91-7.75] years of follow-up, 91 subjects (9.7%) developed cognitive impairment, 27 of them mild cognitive impairment, and 64 dementia. Incidence of cognitive impairment was significantly higher among subjects with subclinical CCS (21.4% versus 9% in those without CCS) and among those with mean MCA-PI>1 (13.5% versus 7.4% in those with MCA-PI<1). In multivariate Cox regression analyses, both CCS and MCA-PI>1 were independently associated with incident cognitive impairment with HR of 2.07 [1.11-3.88] and 1.58 [1.02-2.46], respectively. Subclinical cervico-cerebral stenosis and higher MCA-PI are non-invasive neurosonological markers of incident long-term cognitive impairment in our population.

Sections du résumé

BACKGROUND AND AIMS
We aimed to study subclinical non-invasive vascular markers as predictors of incident long-term cognitive impairment in a longitudinal population-based study.
METHODS
The Barcelona-Asymptomatic Intracranial Atherosclerosis (AsIA) study is a population-based study that included a random sample of 933 Caucasian subjects (mean age 66 years, 64% male) with a moderate-high vascular risk and without history of stroke or dementia. Subclinical carotid and intracranial stenosis was assessed at baseline visit by cervical and transcranial color-coded duplex (TCCD) and confirmed by magnetic resonance angiography. Cervico-cerebral stenosis (CCS) was defined as the presence of extra and/or intracranial stenosis >50%. Baseline middle cerebral artery pulsatility index (MCA-PI) was measured bilaterally by TCCD, and mean PI of both sides was considered for analyses. Subjects were followed-up to determine incident long-term cognitive impairment (mild cognitive impairment or dementia).
RESULTS
After a median of 7.16 [6.91-7.75] years of follow-up, 91 subjects (9.7%) developed cognitive impairment, 27 of them mild cognitive impairment, and 64 dementia. Incidence of cognitive impairment was significantly higher among subjects with subclinical CCS (21.4% versus 9% in those without CCS) and among those with mean MCA-PI>1 (13.5% versus 7.4% in those with MCA-PI<1). In multivariate Cox regression analyses, both CCS and MCA-PI>1 were independently associated with incident cognitive impairment with HR of 2.07 [1.11-3.88] and 1.58 [1.02-2.46], respectively.
CONCLUSIONS
Subclinical cervico-cerebral stenosis and higher MCA-PI are non-invasive neurosonological markers of incident long-term cognitive impairment in our population.

Identifiants

pubmed: 32921430
pii: S0021-9150(20)30469-X
doi: 10.1016/j.atherosclerosis.2020.08.025
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

104-109

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

A M Crespo-Cuevas (AM)

Department of Neurology, Hospital Del Mar - Parc de Salut Del Mar, Barcelona, Spain.

T Canento (T)

Department of Neurology, Hospital Universitari Germans Trias I Pujol, Universitat Autónoma de Barcelona, Barcelona, Spain.

M Hernández-Perez (M)

Department of Neurology, Hospital Universitari Germans Trias I Pujol, Universitat Autónoma de Barcelona, Barcelona, Spain.

C Cáceres (C)

Department of Neurology, Hospital Universitari Germans Trias I Pujol, Universitat Autónoma de Barcelona, Barcelona, Spain.

A González (A)

Department of Neurology, Hospital Universitari Germans Trias I Pujol, Universitat Autónoma de Barcelona, Barcelona, Spain.

L Ispierto (L)

Department of Neurology, Hospital Universitari Germans Trias I Pujol, Universitat Autónoma de Barcelona, Barcelona, Spain.

M Mataró (M)

Department of Clinical Psychology and Psychobiology, Institut de Neurociències, Universitat de Barcelona, Barcelona, Spain; Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.

D Vilas (D)

Department of Neurology, Hospital Universitari Germans Trias I Pujol, Universitat Autónoma de Barcelona, Barcelona, Spain.

A Planas-Ballvé (A)

Department of Neurology, Hospital Sant Joan Despí Moisès Broggi and Hospital General de L'Hospitalet, Consorci Sanitari Integral, Barcelona, Spain.

L Martin (L)

Department of Neurology, Hospital Universitari Germans Trias I Pujol, Universitat Autónoma de Barcelona, Barcelona, Spain.

L Muñoz-Ortiz (L)

Agència de Qualitat I Avaluació Sanitàries de Catalunya (AQuAS), Barcelona, Spain.

J F Arenillas (JF)

Department of Neurology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.

M Via (M)

Department of Clinical Psychology and Psychobiology, Institut de Neurociències, Universitat de Barcelona, Barcelona, Spain; Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.

M Castañón (M)

Department of Neurology, Hospital Universitario Central de Asturias, University of Oviedo, Spain.

M Millan (M)

Department of Neurology, Hospital Universitari Germans Trias I Pujol, Universitat Autónoma de Barcelona, Barcelona, Spain.

L Dorado (L)

Department of Neurology, Hospital Universitari Germans Trias I Pujol, Universitat Autónoma de Barcelona, Barcelona, Spain.

E López-Cancio (E)

Department of Neurology, Hospital Universitario Central de Asturias, University of Oviedo, Spain. Electronic address: elenacancio@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH